US turns to Gilead's COVID-19 drug to help counter omicron

The Food and Drug Administration on Friday broadened its approval of Gilead's COVID-19 drug Veklury to include people who haven't yet been hospitalized, a move meant to help bolster the supply of drugs available to counter the omicron variant.